Browse Category

Stocks News 6 December 2025 - 7 December 2025

Enbridge Stock (ENB) in December 2025: Dividend Hike, 2026 Outlook and AI‑Powered Growth

Enbridge Stock (ENB) in December 2025: Dividend Hike, 2026 Outlook and AI‑Powered Growth

Enbridge stock has moved back into the spotlight in early December 2025 after the Canadian pipeline and utility giant raised its dividend again and issued fresh 2026 financial guidance. For investors watching TSX:ENB and NYSE:ENB as income plays with moderate growth, the latest numbers, regulatory milestones and analyst forecasts paint a clearer picture of what the next few years might…
MSTY Stock Outlook December 2025: What YieldMax’s 100%+ Yield ETF, Reverse Split and Bitcoin Volatility Mean for Investors

MSTY Stock Outlook December 2025: What YieldMax’s 100%+ Yield ETF, Reverse Split and Bitcoin Volatility Mean for Investors

YieldMax MSTR Option Income Strategy ETF (ticker MSTY) has become one of the most watched high-yield ETFs in the market. As of the weekend of 7 December 2025, the fund offers a headline triple‑digit distribution rate, is about to undergo a 1‑for‑5 reverse stock split, and sits in the crosswinds of MicroStrategy (MSTR) and Bitcoin’s latest boom‑and‑pullback cycle. Twelve Data…
NVAX Stock Today: Can Novavax Turn Regulatory Turmoil and Activist Pressure into a Comeback?

NVAX Stock Today: Can Novavax Turn Regulatory Turmoil and Activist Pressure into a Comeback?

Data and news current as of 7 December 2025. NVAX stock price now: where Novavax stands in December 2025 Novavax, Inc. (NASDAQ: NVAX) closed on Friday, 5 December 2025 at $6.91 per share, giving the vaccine maker a market value of around $1.1 billion. Novavax Investor Relations Over the last year, NVAX has slipped roughly 20%, according to data from…
Xpeng Inc (XPEV) Stock in Focus: November 2025 Deliveries, Q3 Earnings Shock, Analyst Targets and 2026 Outlook After Guidance Selloff

Xpeng Inc (XPEV) Stock in Focus: November 2025 Deliveries, Q3 Earnings Shock, Analyst Targets and 2026 Outlook After Guidance Selloff

Xpeng Inc. (NYSE: XPEV) has had one of its most dramatic years since listing – combining record electric‑vehicle (EV) deliveries, a deepening alliance with Volkswagen, ambitious bets on robots and robotaxis, and a Q4 outlook that rattled investors just as the stock hit multi‑year highs. As of the close on December 5, 2025, XPEV finished at $20.00 per share, up…
Celsius Stock Outlook: Is CELH a Buy After the Big Pullback? (December 6, 2025)

Celsius Stock Outlook: Is CELH a Buy After the Big Pullback? (December 6, 2025)

Celsius Holdings (NASDAQ: CELH) has gone from market darling to high‑beta rollercoaster in 2025. After a blistering run earlier in the year, the energy‑drink maker’s stock has sold off sharply despite delivering triple‑digit revenue growth, a new buyback plan and deeper ties with PepsiCo. Here’s a detailed look at the latest Celsius stock news, forecasts and analysis as of December…
Moderna (MRNA) Stock Jumps on Vaccine Safety Study and $1.5B Lifeline: Latest News and Forecasts as of December 6, 2025

Moderna (MRNA) Stock Jumps on Vaccine Safety Study and $1.5B Lifeline: Latest News and Forecasts as of December 6, 2025

Moderna Inc. (NASDAQ: MRNA) is back in the spotlight. After months of pressure from collapsing COVID‑19 vaccine demand and rising regulatory scrutiny, the stock has staged a sharp rebound in early December 2025 — powered by a major long‑term safety study from France and a new $1.5 billion credit facility. Here’s a deep dive into the latest news, forecasts, and…
Tempus AI (TEM) Stock: FDA Wins, Q3 Earnings, and Analyst Forecasts – December 6, 2025

Tempus AI (TEM) Stock: FDA Wins, Q3 Earnings, and Analyst Forecasts – December 6, 2025

Updated: December 6, 2025 Tempus AI Inc. (NASDAQ: TEM) has quickly become one of the most closely watched artificial intelligence stocks in healthcare. After a year marked by multiple FDA clearances, strong revenue growth and high-profile partnerships, Wall Street is now debating whether the current share price in the mid‑$70s still leaves meaningful upside. Business Wire Fresh research notes and…
BlackBerry Stock Outlook: Can BB’s Cybersecurity and QNX Wins Power the Next Leg Higher in 2025–2026?

BlackBerry Stock Outlook: Can BB’s Cybersecurity and QNX Wins Power the Next Leg Higher in 2025–2026?

As of 6 December 2025, BlackBerry Limited (NYSE: BB; TSX: BB) is back on many traders’ and long‑term investors’ watchlists. The former smartphone icon is now a pure‑play software company, leaning heavily on cybersecurity and automotive/IoT software as it heads into a closely watched Q3 fiscal 2026 earnings report on 18 December 2025. Yahoo Finance The big question: after a…
Kinder Morgan (KMI) Stock Outlook 2026: Dividend Strength, LNG Tailwinds and New Pipeline Growth

Kinder Morgan (KMI) Stock Outlook 2026: Dividend Strength, LNG Tailwinds and New Pipeline Growth

Updated: December 6, 2025 Kinder Morgan Inc. (NYSE: KMI) remains one of the most closely watched dividend and infrastructure plays in the U.S. energy sector. As of early December 2025, the stock trades around $27.77 per share, within a 52‑week range of $23.94 to $31.48, giving the company a market capitalization of roughly $62 billion. Investing With a high-yield dividend,…
6 December 2025
GE Aerospace Stock (GE) Today: Price, Dividend, Analyst Targets and 2025–2026 Outlook – December 6, 2025

GE Aerospace Stock (GE) Today: Price, Dividend, Analyst Targets and 2025–2026 Outlook – December 6, 2025

Updated: December 6, 2025 GE Aerospace (NYSE: GE) enters the first weekend of December trading just under recent highs: around $283.94 per share, after a sharp pullback on Friday, even though the stock is still up roughly 60–70% over the past year. Ticker Nerd Behind that performance: a clean break from its old conglomerate structure, repeated earnings beats, raised 2025…
Exxon Mobil (XOM) Stock in December 2025: Dividend Giant Balances Oil Growth, Hydrogen Pause and New Projects

Exxon Mobil (XOM) Stock in December 2025: Dividend Giant Balances Oil Growth, Hydrogen Pause and New Projects

Updated: December 6, 2025 Exxon Mobil Corporation (NYSE: XOM) heads into the final weeks of 2025 trading near the top of its 52‑week range, backed by record production in Guyana and the Permian Basin, a 43‑year dividend growth streak, and a wave of new analyst price targets. At the same time, the company is tightening its petrochemical footprint, pausing a…
Micron Technology (MU) Stock on December 6, 2025: Crucial Exit, AI Memory Supercycle and 2026–2027 Price Targets

Micron Technology (MU) Stock on December 6, 2025: Crucial Exit, AI Memory Supercycle and 2026–2027 Price Targets

Dateline: December 6, 2025 Micron Technology stock has turned into one of 2025’s flagship AI trades. After a brief wobble this week on news that the company is abandoning its long‑running Crucial consumer brand, the shares have snapped back as Wall Street doubled down on the idea of an “AI memory supercycle.” TechStock² Below is a comprehensive look at Micron…
1 52 53 54 55 56 90

Stock Market Today

  • Caterpillar (CAT) Valuation Under Scrutiny Amid Strong Share Price Gains
    January 22, 2026, 12:22 PM EST. Caterpillar (CAT) has surged 10.8% in the past month, reaching $645.38 per share, drawing attention to its valuation. The stock's price-to-earnings (P/E) ratio stands at 32.6x, above the US Machinery industry average of 27.2x and peer average of 25.3x, indicating a premium valuation. Despite this, a fair P/E estimate of 41.6x suggests further upside if growth expectations hold. However, the discounted cash flow (DCF) model values shares at $500.01, hinting the current price may be stretched. Investors must weigh this divergence between earnings multiples and cash flow estimates while considering potential risks if Caterpillar's earnings momentum slows or market sentiment shifts.
Go toTop